Currently, through research on these activation mechanisms, kinases, such as JAK, MAPK, SYK, PI3K, NF-κB, and BTK, are being recognized as major targets for the development of rheumatoid arthritis treatments. Here, BTK is linked to rheumatoid arthritis.